Globalizing newborn screening: bridging gaps in genetic diagnosis and treatment
Frontiers in Pediatrics. 2025-10-16; 13:
DOI: 10.3389/fped.2025.1672993
1. Front Pediatr. 2025 Oct 16;13:1672993. doi: 10.3389/fped.2025.1672993.
eCollection 2025.
Globalizing newborn screening: bridging gaps in genetic diagnosis and treatment.
Tariq H(1)(2), Salpietro V(3), Houlden H(4), Stevanin G(5).
Author information:
(1)Health Biotechnology Division, National Institute for Biotechnology and
Genetic Engineering (NIBGE), Faisalabad, Pakistan.
(2)Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad,
Pakistan.
(3)European Brain Research Institute, Rome, Italy.
(4)Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology,
London, United Kingdom.
(5)CNRS UMR5287, INCIA, EPHE, University of Bordeaux, Bordeaux, France.
DOI: 10.3389/fped.2025.1672993
PMCID: PMC12571786
PMID: 41181182
Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.